Amiodarone Hydrochloride — 150MG, Solution for injection, box of 25 × 3 mL vials

Amiodarone Hydrochloride — 150MG, Solution for injection, box of 25 × 3 mL vials

Amiodarone Hydrochloride is a solution for injection for intravenous use. Amiodarone Hydrochloride Injection, USP is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. Amiodarone Hydrochloride Injection, USP also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication.

• Active ingredient or product type: AMIODARONE HYDROCHLORIDE
• Strength/concentration: 150MG
• Dosage form and route: Solution for injection, Intravenous
• Exact package presentation: box of 25 × 3 mL vials
• NDC/item number: 0143-9875-25
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at 20º-25ºC (68º-77ºF) [See USP Controlled Room Temperature]. Protect from light and excessive heat.
• Status: Rx only

Important safety information: Amiodarone should be administered only by physicians who are experienced in the treatment of life-threatening arrhythmias, who are thoroughly familiar with the risks and benefits of amiodarone therapy, and who have access to facilities adequate for monitoring the effectiveness and side effects of treatment.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.